Innovent Biologics, Inc., a prominent biopharmaceutical firm, announced Fei You as its new Chief Financial Officer (CFO) on Monday, effective from February 5. You are succeeding Ronald Hao Xi Ede, who is set to retire after a seven-year tenure with the company.
Fei You brings over two decades of experience in financial management, strategic investment, and financing. Prior to this, she served as the CFO of Jinxin Fertility Group Ltd. As announced on Friday, the closing stocks of Innovent were reported at $4.085, marking a decline of 2.7%.
